Measuring the risks and rewards of drug development: New research from MIT shows that the success rates of clinical trials are higher than previously thought
The study has broad implications for investors, regulators, policymakers, and clinicians
The study has broad implications for investors, regulators, policymakers, and clinicians
How can we make our financial system less fragile? How can we make our healthcare infrastructure less reactive? What can we do to create more robust civic institutions that work for all of us?
"We’ve made substantial progress… but many risks remain," says Prof. Kristin Forbes.
A new large-scale review, conducted by MIT Sloan Professor Jackson Lu, is the first to systematically examine the psychological, economic, and social effects of air pollution.
The study is the first randomized evaluation of the impact of Clinical Decision Support
Why does the coronavirus kill some Americans, while leaving others relatively unscathed?
In cooperative environments, criticism is likely to have a positive impact on creative brainstorming, whereas in competitive environments, criticism can have a damaging effect on creativity.
Organizations choose to remain small to avoid the cost of regulation, denting growth
A new book by MIT Sloan's JoAnne Yates explores one of the key invisible infrastructures of the modern world: private voluntary industrial standards.
Banks should be reopened first, while cafes and gyms should come much later; places of worship should be opened after colleges and universities, according to the analysis.